Who We Are

Dr. David R. Luke, BScPhm., PharmD, FACA, FCCP

Dr. Luke received his BScPhm degree at the University of Toronto, PharmD degree at the Philadelphia College of Pharmacy and Sciences, and completed a 2-year fellowship in infectious diseases and nephrology at the University of Minnesota. His achievements include 12 NDA approvals in many different therapeutic areas, more than 2 dozen INDs, active participation in FDA meetings, 120+ peer-reviewed publications, 2 chapters, 100+ posters and presentations, and patent holder of initiatives involving HIV, fungal disease, and acute kidney injury. Outside of PhRMA, Dr. Luke has served as an advisory consultant with NASA/Johnson Space Center Steering Committee on the study of drugs in zero-gravity environment, officer of the Connecticut Medical Reserve Corps, and officer of various medical societies. Dr. Luke has held leadership positions at Pfizer Global Research and Development, Roche, Alexion, and Melinta Pharmaceuticals, and recently with Target Health Inc., as well as academic positions at the University of Minnesota, University of Texas MD Anderson Cancer Center, University of Houston College of Pharmacy, and Rutgers College of Pharmacy.

Management team has extensive experiences in biotech business, R&D, deal making, and financing.